EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A dual-aptazyme system for genetic complementation reveals stage-specific roles for the Trypanosoma cruzi cytoskeleton-associated protein 5.5

Justin Wiedeman iD, Ganesh Babu Malli Mohan, Gonzalo Seminario-Mondejar, Ronald Drew Etheridge iD

mSphere · 2026

DOI: 10.1128/msphere.00090-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, 2026. Verfasst von Justin Wiedeman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Protozoan Proteins, Cytoskeletal Proteins, Genetic Complementation Test. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parasitic trypanosomatids, such as Trypanosoma cruzi , Trypanosoma brucei , and Leishmania spp ., cause devastating tropical diseases, with T. cruzi being increasingly recognized as a public health concern in the United States due to established sylvatic cycles and rising autochthonous transmission. Although T. brucei has long served as the model trypanosomatid due to the array of molecular tools available for its study, T. cruzi shares greater biological similarity with the majority of trypanosomatids regarding nutrient uptake, transmission strategy, and metabolism. Recent advancements in genetic tools have now enabled in-depth studies in T. cruzi previously restricted to T. brucei . Here, using the Small Hammerhead Aptazyme-Regulated Knockdown (SHARK) system, we report the characterization of cytoskeleton-associated protein 5.5 (CAP5.5) in T. cruzi . To validate this phenotype, we introduce a novel method for simultaneous knockdown and rescue of a target protein using two tetracycline-responsive aptazymes. Knockdown of CAP5.5 revealed stage-specific roles in the maintenance of cell shape, organelle segregation, and proliferation. To quantify these phenotypes, we leveraged open-source, state-of-the-art segmentation software to develop a semi-automated, high-throughput image analysis pipeline. Our data suggest a potential role for CAP5.5 in repairing motility-related damage to the microtubule cytoskeletal array. These findings demonstrate the emerging utility of T. cruzi as a robust model trypanosomatid. IMPORTANCE Trypanosoma cruzi is the causative agent of Chagas disease, a neglected tropical disease that presents a growing public health concern. Historically, research into T. cruzi biology has been hindered by a scarcity of genetic tools, forcing scientists to rely on models from related but biologically distinct parasites. In this study, we utilize genetic tools (the SHARK conditional knockdown system) to characterize a cytoskeletal protein, CAP5.5, revealing that it is required for the parasite to maintain its shape and divide during its motile stage. We further demonstrate the use of a dual-control system that allows simultaneous gene knockdown and rescue, alongside a new high-throughput 3D imaging pipeline. This work establishes a rigorous technical framework that empowers the community to conduct in-depth investigations of essential T. cruzi genes directly, thus accelerating the discovery of potential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosoma cruziProtozoan ProteinsCytoskeletal ProteinsGenetic Complementation TestGene Knockdown TechniquesAnimalsCytoskeleton

Stichwörter der Autor:innen

CAP5.5Chagas diseaseTrypanosoma cruzicell morphogenesisconditional knockdowncytokinesiscytoskeletonfluorescent image analysisshark

Substanzen

Protozoan ProteinsCytoskeletal Proteins

Autor:innen und Institutionen

  • Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.
  • Department of Cellular Biology, University of Georgia, Athens, Georgia.

ORCID-Profile: Justin Wiedeman, Ronald Drew Etheridge

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute of General Medical Sciences

Zitieren

APA

Wiedeman, J., Malli Mohan, G. B., Seminario-Mondejar, G., & Etheridge, R. D. (2026). A dual-aptazyme system for genetic complementation reveals stage-specific roles for the Trypanosoma cruzi cytoskeleton-associated protein 5.5. mSphere. https://doi.org/10.1128/msphere.00090-26

Vancouver

Wiedeman J, Malli Mohan GB, Seminario-Mondejar G, Etheridge RD. A dual-aptazyme system for genetic complementation reveals stage-specific roles for the Trypanosoma cruzi cytoskeleton-associated protein 5.5. mSphere. 2026. doi:10.1128/msphere.00090-26

BibTeX
@article{Wiedeman2026,
  author = {Wiedeman, Justin and Malli Mohan, Ganesh Babu and Seminario-Mondejar, Gonzalo and Etheridge, Ronald Drew},
  title = {A dual-aptazyme system for genetic complementation reveals stage-specific roles for the Trypanosoma cruzi cytoskeleton-associated protein 5.5},
  journal = {mSphere},
  year = {2026},
  doi = {10.1128/msphere.00090-26}
}
Kostenlos starten →